Arrowhead Pharmaceuticals Presents Preclinical Data on New RNAi-Based Obesity Program ARO-INHBE
Go back to Arrowhead Pharmaceuticals Presents Preclinical Data on New RNAi-Based Obesity Program ARO-INHBE| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 74.30 +2.92 (4.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $71.38 | 52 Week High | $8.22 | |||
| Open | $70.92 | 52 Week Low | $3.07 | |||
| Day High | $74.80 | P/E | N/A | |||
| Day Low | $70.01 | EPS | $-1.30 | |||
| Volume | 3,775,191 | |||||
